Promising Alzheimer’s therapy could soon get FDA approval

“We’d love to halt the progression or reverse the progression (of the disease), but this is the first kind of foot in the door to these more beneficial therapies to really change the course of someone’s disease. For someone with early symptoms, if we can slow it down, that’s six months more independence in a certain task," said Dr. Heidebrink.